Literature DB >> 16396274

The role of protective lead clothing in reducing radiation exposure rates to personnel during equine bone scintigraphy.

Phillip F Steyn1, John Uhrig.   

Abstract

Bone scintigraphy is often used in horses because of its sensitivity and noninvasive nature. A 99mTc labeled radiopharmaceutical is injected at a dose of between 5.7 and 7.3GBq. Images are acquired immediately postinjection and 2-4h post. People are often in the room with the horse during the acquisition process. Objectives of this study were to (a) document the radiation exposure rates at different distances from various sites of the horse at varying times post injection and (b) study the usefulness of wearing lead aprons to reduce exposure rates to personnel. Radiation exposure rates were measured in at three distances (at skin surface and at 30 and 100 cm from the skin) from three sites (shoulder, thorax, and pelvis) in 19 horses. Exposure rates were measured with and without shielding by a 0.5-mm lead equivalent apron during both the pool and delayed phases. A 0.5mm equivalent lead apron significantly decreases radiation exposure (P<0.05) at these three distances from the three sites during both image acquisition phases. Mean dose reduction factors from the lead apron range from 3.6 to 5.7.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16396274     DOI: 10.1111/j.1740-8261.2005.00097.x

Source DB:  PubMed          Journal:  Vet Radiol Ultrasound        ISSN: 1058-8183            Impact factor:   1.363


  2 in total

1.  An Investigation to Determine an Optimum Protective Garment Material in Nuclear Medicine.

Authors:  R Parvaresh; A Haghparast; K Khoshgard; M Jalili; M T Eivazi; M Ghorbani
Journal:  J Biomed Phys Eng       Date:  2018-12-01

2.  Evaluation of Annual Staff Doses and Radiation Shielding Efficiencies of Thyroid Shield and Lead Apron during Preparation and Administration of 131I, 81Kr, and 99mTc-Labeled Radiopharmaceuticals.

Authors:  Nayereh Khalili; Seyed Salman Zakariaee; Elahe Jazayeri Gharebaghi; Yalda Salehi; Vahid Changizi
Journal:  J Med Signals Sens       Date:  2021-12-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.